Value Bridge — TEXAS HEALTH H-E-B
Current $4M → Target $10M (+$6.4M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$3.7M
Current EBITDA
$10.1M
Target EBITDA
+$6.4M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$1.5M
Payer Mix Optimization
$3.5M
Cost to Collect Reduction
$1.2M
Clean Claim Improvement
$0.9M
Volume & Rate Growth
$5.8M
What This Means
The 7-lever model projects a 174% EBITDA uplift from $4M to $10M. The highest-impact lever is Volume & Rate Growth at $2.3M probability-weighted.
IC talking point: "We see $6M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $71M in equity value creation."